HOXA9 and cancer: The overexpressed HOXA9 activates TGFβ2 and promotes the transformation of normal peritoneal fibroblasts and normal adipose and bone marrow–derived mesenchymal stem cells (MSCs) into cancer-associated fibroblasts (CAFs) (Ko et al. 2012).